Practical management of patients with myelofibrosis receiving ruxolitinib
Author:
Publisher
Informa UK Limited
Subject
Hematology
Link
http://www.tandfonline.com/doi/pdf/10.1586/17474086.2013.827413
Reference53 articles.
1. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
2. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
3. Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium
4. Primary Myelofibrosis: Update on Definition, Pathogenesis, and Treatment
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pyrazole: an emerging privileged scaffold in drug discovery;Future Medicinal Chemistry;2023-11
2. Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis;Expert Review of Hematology;2022-06-14
3. Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 ( JAK2 ), in patients with myelofibrosis and low pretreatment platelet counts;British Journal of Haematology;2022-04-27
4. Synthesis of Four Heterocyclic Drug Molecules Repurposed for COVID-19;Mini-Reviews in Organic Chemistry;2022-03
5. Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study;Leukemia;2021-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3